New York Times: Those in the peptide trade, who identified themselves simply as a researcher, physician or pharmacist, said they were swayed by reports from members of the public who testified moments earlier.
“Even with the limited data that we have, it wasn’t a significant signal in terms of risk,” said Asare Christian, the founder of a Philadelphia-area clinic that sells BPC-157 “for healing.”
He added: “We are always taking risk with patients, with all the interventions we do as physicians.”…